SARS-CoV-2 IVDs: Products not accepted for EUL pdf
Updated SARS-CoV-2: IVD applications under assessment for Emergency Use Listing pdf
Screening checklist for biotherapeutic products and their corresponding SBPs - Abridged Pathway docx
Screening checklist for biotherapeutic products and their corresponding SBPs - Full Pathway docx
Screening checklist for generic products doc
Section guidance for part 3 — patient information leaflet (PIL) — of a WHO Public Assessment Report (WHOPAR) (24 October 2016) pdf
Section guidance for part 4 — summary of product characteristics (SmPC) — of a WHO Public Assessment Report (WHOPAR) (25 October 2016) pdf
Section guidance for part 5 — labelling — of a WHO Public Assessment Report (WHOPAR) (24 October 2016) pdf
Section guidance for part 6 of — scientific discussion — of a WHO Public Assessment Report (WHOPAR) (25 October 2016) pdf
Sinovac TAG Report CoronaVacTM pdf
Solar autonomy calculator xls
Stability testing of active pharmaceutical ingredients and finished pharmaceutical products - WHO Technical Report Series, No.1010, Annex 10, 2018 pdf
Standard operating procedure 001: How to develop and publish a PQS product performance specification (1 April 2020) pdf
Standard operating procedure 002: How to review and revise a PQS product performance specification (1 April 2020) pdf
Standard operating procedure 003: How to withdraw a PQS product performance specification (1 April 2020) pdf
Standard operating procedure 004: How to develop and publish a PQS product verification protocol (1 April 2020) pdf
Standard operating procedure 005: How to review and revise a PQS product verification protocol (1 April 2020) pdf
Standard operating procedure 006: How to withdraw a PQS product verification protocol (1 April 2020) pdf
Standard operating procedure 007: How to assess a laboratory for PQS accreditation (1 April 2020) pdf
Standard operating procedure 008: How to re-evaluate a WHO PQS-accredited test laboratory (1 April 2020) pdf
Standard operating procedure 009: How to evaluate applications for product prequalification (1 April 2020) pdf
Standard operating procedure 010: How to re-evaluate a prequalified PQS product (1 April 2020) pdf
Standard operating procedure 011: How to remove a prequalified product from the PQS database (1 April 2020) pdf
Standard operating procedure 012: How to field test a PQS product (1 April 2020) pdf
Standard operating procedure 013: How to obtain feedback on the performance of a PQS product (1 April 2020) pdf
Standard operating procedure 014: How to audit a laboratory for PQS accreditation (1 April 2020) pdf
Status of COVID-19 vaccines within WHO EUL/PQ evaluation process pdf
Stringent regulatory authority sharing of non-public information concerning product with the national regulatory authority and the World Health Organization (WHO), Annex 3A docx
Summary of FPPs and APIs invited for prequalification xlsx
Summary of product characteristics (SmPC) template (24 October 2016) docx
Summary of Service Codes - Vector Control pdf
Sure Status Covid-19 Antigen Test Card IFU pdf
Survey of the quality of anti-tuberculosis medicines circulating in selected newly independent states of the former Soviet Union (issued November 2011) pdf
Survey of the quality of antiretroviral medicines circulating in selected African countries (issued September 2007) pdf
Survey of the quality of medicines identified by the United Nations Commission on Life Saving Commodities for women and children pdf
Survey of the quality of selected antimalarial medicines circulating in six countries of sub-Saharan Africa (issued January 2011) pdf
Survey of the quality of selected antiretroviral medicines circulating in five African countries (2019) pdf
Syphilis rapid tests under assessment pdf
